Redefining MTM in the Post-health Reform Era

The healthcare industry has hit a crossroads that requires a strategic choice regarding the most effective allocation and use of clinical pharmacy resources on the path to performance improvement. As value-based care models drive the need for greater collaboration across clinical settings, the critical role of pharmacy expertise is heightened to accommodate a greater focus on ensuring medication effectiveness and minimizing potential for medication-related harm — a national crisis that has become the focal point of the risk-bearing regulatory landscape.

Download White Paper

You may also like:

Blog Post

A recent study using Medicaid enrollee data showed that medical marijuana laws and adult-use marijuana laws were associated with lower opioid prescribing rates. A second study using data from the Medicare Part D population foun...

View Blog Post
Blog Post

It may not be exciting or cutting-edge, but the pharmaceutical supply chain and pharmacy profession’s operations are tied to an infrastructure that depends on a 10- or 11-digit number: the

View Blog Post
Blog Post

A recent study found the use of non-steroidal anti-inflammatory drugs (NSAIDs) in combination with oral anticoagulant therapy in patients with atrial fibrillation was associated with an increased risk of major bleeding compared...

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up